Berkshire's Surge: Key Holdings Drive 8-Month Highs

Berkshire Hathaway (BRK.B) closed Tuesday at $512.37, its strongest level since late November, as a UBS price-target upgrade and surging equity holdings narrowed the stock’s S&P 500 deficit by more than half in two months.

With second-quarter results due August 8 and reports of up to $11 billion in share buybacks, investors have fresh catalysts to weigh against lingering weakness in the conglomerate’s railroad and insurance units.

Key Takeaways

BRK.B hit $512.37 Tuesday, highest close since November 28.
S&P 500 gap cut from 17.5 points to roughly 7.6 points.
Q2 earnings on August 8 may confirm ~$11 billion buyback.

Market Reaction & Context

Berkshire’s Class B shares ended the week at $511.54, still 5.2% below their all-time closing high of $539.80 reached on May 2, 2025 – the day before Warren Buffett revealed he would step down as chief executive at year-end.¹ The Class A shares mirrored the move, touching $768,010 on Tuesday before settling at $766,600, a 5.3% discount to their own record of $809,350.

Against the broader market, Berkshire remains a laggard on a year-to-date basis, trailing the S&P 500 by 7.6 percentage points as of Friday’s close.² Yet that gap has compressed sharply: just two months ago the deficit stood at 17.5 points, meaning Berkshire has recaptured more than half the ground in a matter of weeks.

Detailed Analysis

Three heavyweight equity positions have done much of the heavy lifting in Berkshire’s recovery.³ Apple (AAPL), the conglomerate’s largest listed holding at a market value exceeding $70 billion, has gained 13.6% year-to-date.

Coca-Cola (KO), Berkshire’s third-largest stake valued at $35 billion, has surged 25% in 2026 after beating quarterly earnings estimates and raising its full-year outlook.⁴ Bank of America (BAC), the fourth-largest position at nearly $32 billion, has added 12.6% on the year, reflecting broader financial-sector resilience.

The rally on Tuesday – when BRK.B gained roughly 3% in a single session – coincided with a price-target increase from UBS analyst Brian Meredith, who lifted his B-share target to $585 from $570 and his A-share target to $877,848 from $854,596 while maintaining a buy rating.¹ Meredith also edged his earnings estimates higher.

A separate Barron’s report flagged that Berkshire may have repurchased as much as $11 billion of its own stock in the second quarter – a figure that would dwarf the $234 million bought back in Q1 2026.¹ Management has historically deployed buybacks when it views shares as trading below intrinsic value, and confirmation of that scale would signal high conviction at current prices.

Headwinds in Core Operations

The recovery story is not without friction. Berkshire’s railroad operations and insurance segment have both lagged comparable competitors, representing a meaningful drag on the conglomerate’s operating earnings.³ Insurance underwriting discipline and freight-volume trends will be closely watched in the August 8 report.

Berkshire’s cash pile – standing at approximately $397.4 billion as of March 31 – provides an offsetting strategic buffer, giving successor CEO Greg Abel the optionality to pursue acquisitions or extend buybacks if valuations remain attractive.¹ Excluding railroad cash and subtracting T-bills payable, the adjusted figure sits at $380.2 billion, up 3% from year-end 2025.

Analyst Quote & Outlook

“The rally has room to run since the stock remains well behind the benchmark,” Barron’s said, citing the 7.6 percentage point gap that persists even after Berkshire’s recent outperformance.¹

UBS’s Meredith echoed that constructive tone with his upgraded price targets, suggesting the market has not yet fully priced in the combination of portfolio gains, potential buyback activity, and Berkshire’s fortress-level cash position.¹ Berkshire also recently agreed to acquire $10 billion in Alphabet shares directly from the company, adding a significant technology overlay to its investment portfolio.¹

Conclusion

Berkshire Hathaway’s eight-month high reflects a convergence of equity tailwinds, analyst re-rating, and buyback speculation rather than a single catalyst.² The August 8 earnings release will be the next definitive test, with investors focused on actual repurchase figures, insurance underwriting margins, and any guidance signals from the Abel-led management team.

The conglomerate’s market capitalization stands at approximately $1.1 trillion, and its trailing price-to-earnings ratio of 15.23x leaves room for re-rating if operating results support the current momentum.¹

Not investment advice. For informational purposes only.